אימנד 150 מ"ג IV
国家: 以色列
语言: 希伯来文
来源: Ministry of Health
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG
可用日期:
MERCK SHARP & DOHME ISRAEL LTD
ATC代码:
A04AD12
药物剂型:
POWDER FOR SOLUTION FOR INFUSION
给药途径:
I.V
厂商:
MERCK SHARP & DOHME B.V, HOLLAND
治疗组:
APREPITANT
疗效迹象:
Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
授权日期:
2011-11-01
